0.86
-0.58%
Close of 9 Nov 2026, in HKD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Dingdang Health Technology Group
Its shares trade on HKEX under the ticker 9886.HK. It has been listed since 14 September 2022. In the fiscal year to 31 December 2025, it reported revenue of CN¥5.70bn and a net loss of CN¥57.2m. At that date it held total assets of CN¥3.31bn and shareholders' equity of CN¥1.94bn.
Dingdang Health Technology Group Ltd. is an investment holding company, which engages in the provision of pharmaceutical and healthcare solutions. The company is headquartered in Beijing, Beijing. The company went IPO on 2022-09-14. The firm operates two segments. The Pharmaceutical and Healthcare Business segment is engaged in online direct sales, business distribution, offline smart pharmacies, express delivery services, and online medical consultation. The Others segment provides marketing services, marketplace services and other services. The firm mainly conducts businesses within the domestic market.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Consumer Staples
- Industry
- Consumer Staples Distribution & Retail
- Listed since
- 14 Sept 2022
- Employees
- 2,605
- Website
- ddjkjt.com ↗
Leadership
Pay as last reported
- Mr. Wenlong YangExecutive Chairman of the Board, President, since 2014CN¥236.4m
- Mr. Yiu Por LamChief Financial Officer, Joint Company Secretary
- Mr. Qinglong YuChief Technology Officer, Executive Director, since 2021CN¥2.5m
- Mr. Ning XuVice President, Executive Director, since 2021CN¥2.0m
- Mr. Lei YuVice President, Executive Director, since 2021CN¥3.1m
- Mr. Yibin YangExecutive Director, since 2023
- Mr. Zhenxuan LiuJoint Company Secretary
- Ms. Chuheng LiNon-Executive Director
- Mr. Zhenhong FanIndependent Non-Executive Director
- Mr. Shan JiangIndependent Non-Executive Director
- Mr. Shouchuan ZhangIndependent Non-Executive Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Headquartered in Beijing with 2,605 employees
- Operates two business segments: Pharmaceutical and Healthcare Business and Others
- Provides online direct sales, offline smart pharmacies, and medical consultation services
Weaknesses
- Relies solely on the domestic market for business operations
- IPO occurred in 2022, indicating a relatively new public company
- No mention of international presence or global market expansion
Opportunities
- Expansion into international markets beyond the domestic market
- Growth potential in online medical consultation and express delivery services
- Potential for increased market share in pharmaceutical and healthcare solutions
Threats
- Dependence on domestic market may limit growth opportunities
- New public company status could lead to volatility in stock performance
- Competition in the domestic pharmaceutical and healthcare sector
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.